NDC 17033-451 - Clavacillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17033-451
- Package NDCs from labels
- 17033-451-15
- Manufacturer
- Dechra Veterinary Products, LLC
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clavacillin - Dechra Veterinary Products, LLC | Dechra Veterinary Products, LLC | 2026-04-03 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17033-451-15 | Clavacillin | 15 mL in 1 VIAL, GLASS | POWDER, FOR SUSPENSION | 15 | 5 | |
| 17033-451-15 | Clavacillin | 1 in 1 CARTON | POWDER, FOR SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin | AMOXICILLIN | Rising Pharma Holdings, Inc. | bbe590a0-4196-4885-b679-cc1833af567f | 2024-02-27 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Sandoz Inc | 13bd4214-9b7f-425b-af5f-fc1ddc678230 | 2024-02-22 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | 116f655e-e32f-5030-e063-6394a90a64e5 | 2024-02-15 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | 0d40bc70-8f47-48c2-a7c6-ba7db9cace74 | 2024-02-01 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Hikma Pharmaceuticals USA Inc. | d46f1091-33dc-4f8f-9c34-75dcfedb4b4c | 2024-02-01 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Hikma Pharmaceuticals USA Inc. | 077f4a65-3cfb-4cb1-99f2-e27ffc5939c0 | 2024-02-01 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Aurobindo Pharma Limited | 7e3a4517-1934-4e03-b96b-4ad65ab076c5 | 2024-01-23 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN | AMOXICILLIN | DIRECT RX | 0173e9de-a995-4386-bb65-8fc2bbf347f9 | 2024-01-09 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Proficient Rx LP | 66404ced-5ef4-4a31-9276-8c6f86add61c | 2024-01-01 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Proficient Rx LP | fcdaba34-373f-4d4e-8203-76f02e3bb00a | 2024-01-01 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 00fbd46e-05fd-4f8a-9f59-a7a4d01c8e54 | 2023-12-18 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | cef5b1ae-8454-4e7a-8830-dd5d601c1d21 | 2023-12-09 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | ca2886d0-7be7-4d41-bad5-df3ad44e0e7e | 2023-12-09 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 4eee2b38-ca84-421d-87e1-031bc5a3f3a7 | 2023-11-24 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 8bac30bb-1dbc-41de-ad50-0a1883f96198 | 2023-11-17 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 61f9224b-a91b-4154-a7f3-22c14601230f | 2023-10-31 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | e05caabb-b95c-4e54-890e-bbc371a20fc3 | 2023-10-01 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 156ef8e9-b6e4-4512-865f-7139c90c8f9b | 2023-09-10 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Asclemed USA, Inc. | f14a8008-c0ff-4628-af99-e5f07b19df71 | 2023-09-06 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Asclemed USA, Inc. | 8c4125d4-d074-40d4-9def-d3a528fc8c8e | 2023-09-06 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.